+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives

Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives

Psychopharmacology 233(10): 1765-1777

Several lines of evidence suggest that endocannabinoid and nicotinic cholinergic systems are implicated in the regulation of different physiological processes, including reward, and in the neuropathological mechanisms of psychiatric diseases, such as addiction. A crosstalk between these two systems is substantiated by the overlapping distribution of cannabinoid and nicotinic acetylcholine receptors in many brain structures. We will review recent preclinical data showing how the endocannabinoid and nicotinic cholinergic systems interact bidirectionally at the level of the brain reward pathways, and how this interaction plays a key role in modulating nicotine and cannabinoid intake and dependence. Many behavioral and neurochemical effects of nicotine that are related to its addictive potential are reduced by pharmacological blockade or genetic deletion of type-1 cannabinoid receptors, inhibition of endocannabinoid uptake or metabolic degradation, and activation of peroxisome proliferator-activated-receptor-α. On the other hand, cholinergic antagonists at α7 nicotinic acetylcholine receptors as well as endogenous negative allosteric modulators of these receptors are effective in blocking dependence-related effects of cannabinoids. Pharmacological manipulation of the endocannabinoid system and endocannabinoid-like neuromodulators shows promise in the treatment of nicotine dependence and in relapse prevention. Likewise, drugs acting at nicotinic acetylcholine receptors might prove useful in the therapy of cannabinoid dependence. Research by Steven R. Goldberg has significantly contributed to the progress in this research field.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 058135756

Download citation: RISBibTeXText

PMID: 26728894

DOI: 10.1007/s00213-015-4196-3

Related references

Nicotinic-catecholaminergic interactions in rat brain: evidence for cholinergic nicotinic and muscarinic interactions with hypothalamic epinephrine. Journal of Pharmacology and Experimental Therapeutics 221(2): 416-420, 1982

Cholinergic dopaminergic interactions in radial arm maze performance role of nicotinic cholinergic systems. Society for Neuroscience Abstracts 14(2): 1136, 1988

Preclinical Evidence for a Role of the Nicotinic Cholinergic System in Parkinson's Disease. Neuropsychology Review 25(4): 371-383, 2015

Nicotinic cholinergic signaling in adipose tissue and pancreatic islets biology: revisited function and therapeutic perspectives. Archivum Immunologiae et Therapiae Experimentalis 62(2): 87-101, 2014

Cholinergic stimulation of skeletal muscle alanine and glutamine formation and release. Evidence for mediation by a nicotinic cholinergic receptor and guanosine 3':5'-monophosphate. Journal of Biological Chemistry 253(21): 7924-7930, 1978

Therapeutic perspectives of inhibitors of endocannabinoid degradation. Current Drug Targets. Cns and Neurological Disorders 4(6): 697-707, 2005

Therapeutic Perspectives of Inhibitors of Endocannabinoid Degradation. Current Drug Target -Cns and Neurological Disorders 4(6): 697-707, 2005

The role of the endocannabinoid system in eating disorders: neurochemical and behavioural preclinical evidence. Current Pharmaceutical Design 20(13): 2089-2099, 2014

Potential interactions between hippocampal cholinergic and dopaminergic systems Evidence from receptor autoradiography and in vivo dialysis. Society for Neuroscience Abstracts 19(1-3): 304, 1993

Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives. Seminars in Arthritis and Rheumatism 29(2): 65-81, 1999

The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings. Pharmacological Research 111: 668-678, 2016

The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives. Journal of Psychopharmacology 26(1): 150-163, 2012

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends in Pharmacological Sciences 30(8): 411-420, 2009

Light and electron microscopic study of cholinergic and noradrenergic elements in the basolateral nucleus of the rat amygdala: Evidence for interactions between the two systems. Journal of Comparative Neurology 439(4): 411-425, 2001

Interactions of the cholinergic and serotonergic systems: Re-evaluation of conditions for inhibition of acetylcholinesterase by serotonin and evidence for a new inhibitor derived from this natural indoleamine. General Pharmacology: The Vascular System 11(1): 37-45, 1980